Munar Pharma S.A. (WSE:MUN)
Poland · Delayed Price · Currency is PLN 0.3090
0.00 (0.00%)
At close: Sep 3, 2026
Munar Pharma Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15 | 6 | 4 | 14 | 19 | 23 | |
Market Cap Growth | 120.14% | 51.64% | -70.53% | -27.37% | -15.17% | -44.57% |
Enterprise Value | 14 | 6 | 4 | 14 | 19 | 22 |
Last Close Price | 0.32 | 0.37 | 0.24 | 0.83 | 1.14 | 1.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 36.05 | - | - | - |
PS Ratio | 59.94 | 25.12 | 16.51 | 6.49 | 6.52 | 10.81 |
PB Ratio | 14.36 | 5.30 | -3.91 | -11.97 | 7.35 | 8.34 |
P/TBV Ratio | 14.36 | 5.30 | - | - | 9.12 | 9.35 |
P/FCF Ratio | - | - | - | 86.50 | - | - |
P/OCF Ratio | - | - | - | 86.50 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 54.29 | 25.23 | 16.45 | 6.65 | 6.45 | 10.66 |
EV/EBITDA Ratio | - | - | - | - | 97.30 | - |
EV/EBIT Ratio | - | - | - | - | 99.83 | - |
EV/FCF Ratio | - | - | - | 88.62 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | -0.06 | -0.06 | - | 0.01 |
Debt / FCF Ratio | - | - | - | 0.46 | - | - |
Net Debt / Equity Ratio | -1.35 | -1.39 | -0.05 | 0.14 | -0.07 | -0.21 |
Net Debt / EBITDA Ratio | 1.94 | 2.24 | -0.12 | 0.17 | -0.98 | 0.53 |
Net Debt / FCF Ratio | 2.33 | 1.43 | -0.04 | -0.99 | 0.53 | 0.35 |
Asset Turnover | - | 0.22 | 0.45 | 0.85 | 0.65 | 0.52 |
Quick Ratio | 2.43 | 2.52 | 0.19 | 0.31 | 1.02 | 0.92 |
Current Ratio | 2.43 | 2.52 | 0.19 | 0.31 | 2.46 | 2.56 |
Return on Equity (ROE) | - | -1199.39% | - | -643.58% | -13.81% | -48.89% |
Return on Assets (ROA) | - | -40.82% | -47.37% | -23.90% | 2.61% | -17.31% |
Return on Invested Capital (ROIC) | - | - | - | -153.17% | 8.36% | -59.12% |
Return on Capital Employed (ROCE) | -69.40% | -61.90% | 40.80% | 82.60% | 7.30% | -35.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.82% | -12.04% | 2.77% | -33.42% | -1.76% | -4.52% |
FCF Yield | -4.05% | -18.35% | -27.25% | 1.16% | -1.88% | -7.38% |
Buyback Yield / Dilution | -176.72% | -176.72% | 0.00% | - | -0.46% | -12.50% |